ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
182 hedge funds and large institutions have $1.44B invested in ChemoCentryx, Inc. in 2022 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 72 increasing their positions, 52 reducing their positions, and 30 closing their positions.
292% more call options, than puts
Call options by funds: $40.3M | Put options by funds: $10.3M
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
38% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 52
30% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 30
3% more funds holding
Funds holding: 176 → 182 (+6)
3% more capital invested
Capital invested by funds: $1.4B → $1.44B (+$40.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$29.5M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$22.6M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$19.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.1M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$13.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$29.5M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$29M |
| 3 |
PA
Perceptive Advisors
New York
|
-$26.7M |
| 4 |
Millennium Management
New York
|
-$20.5M |
| 5 |
Two Sigma Investments
New York
|
-$17M |
CCXI Hedge Fund Activity: Q2 2022 in Review
182 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2022, worth a combined $1.44B — up 2.9% from $1.4B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new CCXI positions and 30 closed out — a net gain of 9 holders — while 72 added to existing stakes and 52 trimmed.
The largest buyer was Hood River Capital Management, opening a new position worth an estimated $29.5M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $29.5M sold.
- 182 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2022, up from 176 in Q1 2022.
- Funds reported $1.44B of ChemoCentryx, Inc. stock for Q2 2022, up 2.9% quarter-over-quarter.
- 39 funds opened new ChemoCentryx, Inc. positions in Q2 2022 and 30 closed out, a net change of +9 holders.
- The largest ChemoCentryx, Inc. buyer in Q2 2022 was Hood River Capital Management, an estimated $29.5M added.
- The largest ChemoCentryx, Inc. seller in Q2 2022 was Avidity Partners Management, an estimated $29.5M sold.
Based on aggregated 13F filings for Q2 2022.